Delivery Order SPE2DB24D2100-SPE2DB25FBBWN

Award Date 1/27/25
Potential Completion Date 1/28/25
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $33,105.03 and an ultimate completion date of December 18, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 17, 2024. This appears to be a delivery order contract, with a firm fixed price pricing type. The contract...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML medical products to the Defense Logistics Agency (DLA), a defense agency. The $1,574.56 contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on November 26, 2024 with a completion date of November 27, 2024. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical products to the Defense Logistics Agency (DLA). The $3,043.90 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on July 24, 2024. The contract has an ultimate completion date of July 25, 2024 and is not set aside for any small business designation. Amerisourcebergen has been awarded numerous indefinite delivery contracts (IDCs) by the...
The federal contract award is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with a ceiling value of $4,723.68. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 4, 2024. There is no set-aside designation for this...
This federal contract award is for the delivery of COSENTYX 300 MG DOSE-2 PEN SML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract has a ceiling value of $80,433.40 and was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 27, 2023. This contract is not designated with a...
This federal contract award is for the delivery of 4,565,107,314 units of the COSENTYX UNOREADY 300 MG PEN 2ML pharmaceutical product to the Defense Logistics Agency (DLA) under a Firm Fixed Price Delivery Order. The contract has a ceiling value of $7,609.75 and an ultimate completion date of July 17, 2024. The prime contractor is Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense...
This federal contract award, valued at $10,004.00, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, and has an ultimate completion date of March 24, 2025. The contract type is Delivery Order with a Firm Fixed Price pricing structure. The contract is not designated as a set-aside. Amerisourcebergen...
This federal contract award is for the delivery of COSENTYX SENSOREADY 150 MG PENML pharmaceutical products to the Defense Logistics Agency (DLA). The $19,882.00 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 31, 2024 and was not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a significant...
This federal contract award is for the delivery of Cosentyx Unoready 300 mg pen injectors to the Defense Logistics Agency (DLA) Troop Support Medical. The $7,837.91 firm fixed price contract was awarded to prime contractor AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 17, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) held by...
This federal contract award, with ID SPE2DX15D1053|SPE2DX25F6BLF, is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which has a ceiling value of $1,521.95, is a delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a Firm Fixed Price arrangement with an ultimate completion date of October 9, 2024. It is not designated as a set-aside...
  • SPE2DB24D2100
    Indefinite Delivery Contract
  • SPE2DB24D2100-SPE2DB25FBBWN
    Delivery Order

This federal contract award is for the delivery of COSENTYX UNOREADY 300 MG PEN 2ML, a pharmaceutical product, to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $10,760.60 and was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 28, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/28/25, 9:56 AM